Dr. Sang Bong Lee is a distinguished researcher in nuclear medicine, molecular imaging, and biophotonics, focusing on the development of theranostic nanoplatforms for cancer and inflammatory diseases. He has pioneered NMDAR-targeted imaging probes for tracking M1 macrophages and immune cells, enabling precise visualization of disease processes. His work on radionuclide-embedded gold and silica nanoparticles has advanced the field of molecular diagnostics and image-guided therapy. Dr. Lee has established bioadhesive orthotopic and metastatic colorectal cancer models that closely mimic human clinical conditions, providing improved platforms for translational research. He has innovated 4D-printed microrobot-based drug delivery systems that enhance targeted therapy and personalized medicine. His research integrates nanomedicine, molecular imaging, and advanced biomaterials to develop clinically relevant therapeutics. In addition, he leads the creation of cardiovascular and neurovascular intervention simulators, which combine physical vascular models, pulsatile pumps, and AI-enhanced virtual X-ray imaging to offer realistic, radiation-free training for interventional cardiologists and neurointerventionists. Dr. Lee’s work spans fundamental science to translational applications, bridging multidisciplinary fields including chemistry, medicine, engineering, and materials science. He has published extensively in SCI/SCIE-indexed journals and holds multiple patents in theranostic nanoc
Dr. Sang Bong Lee is a distinguished researcher in nuclear medicine, molecular imaging, and biophotonics, focusing on the development of theranostic nanoplatforms for cancer and inflammatory diseases. He has pioneered NMDAR-targeted imaging probes for tracking M1 macrophages and immune cells, enabling precise visualization of disease processes. His work on radionuclide-embedded gold and silica nanoparticles has advanced the field of molecular diagnostics and image-guided therapy. Dr. Lee has established bioadhesive orthotopic and metastatic colorectal cancer models that closely mimic human clinical conditions, providing improved platforms for translational research. He has innovated 4D-printed microrobot-based drug delivery systems that enhance targeted therapy and personalized medicine. His research integrates nanomedicine, molecular imaging, and advanced biomaterials to develop clinically relevant therapeutics. In addition, he leads the creation of cardiovascular and neurovascular intervention simulators, which combine physical vascular models, pulsatile pumps, and AI-enhanced virtual X-ray imaging to offer realistic, radiation-free training for interventional cardiologists and neurointerventionists. Dr. Lee’s work spans fundamental science to translational applications, bridging multidisciplinary fields including chemistry, medicine, engineering, and materials science. He has published extensively in SCI/SCIE-indexed journals and holds multiple patents in theranostic nanoc